Previous, we have demonstrated that dipeptidyl peptidase-4 (DPP-4) inhibitor lowers OAT vasculopathy in rats through direct increase in GLP-1 activity, and regulates SDF-1α levels and EPCs function [69]. The gene discussed is CXCL12; the disease is vascular disorder.